Table of Contents Table of Contents
Previous Page  330 / 374 Next Page
Information
Show Menu
Previous Page 330 / 374 Next Page
Page Background

Manejo de la inmunoterapia en atención primaria

330

et al. Indicación de la ITE en la edad

pediátrica. Evidencias en Pedaitría.

2011;7:78.

15. Casanovas M, Martín R, Jiménez C,

Caballero R, Fernández-Caldas E. Safe-

ty of immunotherapy with therapeutic

vaccines containing depigmented and

polymerized allergen extracts. Clin

Exp Allergy. 2007;37(3):434.

16. Casanovas M, Martín R, Jiménez C,

Caballero R, Fernández-Caldas E. Safe-

ty of immunotherapy with therapeutic

vaccines containing depigmented and

polymerized allergen extracts. Clin

Exp Allergy. 2007;37(3):434.

17. Roy SR, Sigmon JR, Olivier J, Moffitt

JE, Brown DA, Marshall GD. Increa-

sed frequency of large local reactions

among systemic reactors during sub-

cutaneous allergen immunothera-

py. Ann Allergy Asthma Immunol.

2007;99(1):82.

18. Lin SY, Erokosima N, Kim JM, Rame-

nathan M, Súarez-Cuervo C, Challadu-

rai Y, et al. Sublingual immnotherapy

for the treatment of allergic rhinocon-

juctivitis and asthma:a systematic re-

view. JAMA. 2013;27:309(12):1278-88.

19. Canonica GW, Bousquet J, Casa-

le T, Lockey RF, Baena-Cagnani CE,

Pawankar R, et al. Sub-lingual immu-

notherapy: World Allergy Organization

Position Paper. Allergy. 2009;64(Suppl.

91):1-59.

20. Eifan AO, Akkoc T, Yildiz A, Keles S,

Ozdemir C, Bahceciler NN, et al. Clini-

cal efficacy and immunological mecha-

nisms of sublingual and subcutaneous

immunotherapy in asthmatic/rhinitis

children sensitized to house dust mite:

an open randomized controlled trial.

Clin Exp Allergy 2010; 40:922-32.

21. Grupo deTrabajo de Inmunoterapia. For-

mulario de registro de reacciones adver-

sas con inmunoterapia. SEICAP [en lí-

nea]. Disponible en: http:// www.seicap.

es/ver-informe.asp?sec=45&msg=

1588&s1=

22. Iglesias-Cadarso A, Hernández-Wei-

gand P. Risk factors for systemic re-

actions to allergen immunothera-

py. Curr Opin Allergy Clin Immunol.

2011;11(6):579-85.

23. Sociedad Española de Alergología e

Inmunología Clínica. SEAIC [en línea].

Disponible en:

http://www.seaic.org/

24. Guardia P. Recomendaciones para el

manejo de Inmunoterapia. Servicio

Andaluz de Salud; 2004 [en línea]. Dis-

ponible en:

http://goo.gl/YJWCNq